The incidence of esophageal adenocarcinoma continues to rise: Analysis of period and birth cohort effects on recent trends

Annals of Oncology

Volumn 23, Issue 12, 2012, Pages 3155-3162

  Thrift, A P ^a,b   Whiteman, D C ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Age period cohort models; Annual percentage change; Epidemiology; Esophageal adenocarcinoma; Incidence; Secular trends

Indexed keywords

ARTICLE; AUSTRALIA; BIRTHPLACE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CARDIA CARCINOMA; COHORT ANALYSIS; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; SWEDEN; UNITED STATES;

EID: 84869827579     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds181     Document Type: Article

References (48)

1. Lagergren J, Bergstrom R, Lindgren A et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 2000; 85: 340-346.
2. Pandeya N, Williams G, Green AC et al. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology 2009; 136: 1215-1224.
3. Pandeya N, Williams GM, Sadhegi S et al. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am J Epidemiol 2008; 168: 105-114.
4. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-146.
5. Newnham A, Quinn MJ, Babb P et al. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998. Aliment Pharmacol Ther 2003; 17: 665-676.
6. Bollschweiler E, Wolfgarten E, Gutschow C et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549-555.
7. Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 2009; 101: 855-859.
8. Lagergren J, Mattsson F. No further increase in the incidence of esophageal adenocarcinoma in Sweden. Int J Cancer 2011; 129: 513-516.
9. Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev 2010; 19: 1468-1470.
10. Lord RVN, Law MG, Ward RL et al. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol 1998; 13: 356-362.
11. Stavrou EP, McElroy HJ, Baker DF et al. Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005. Med J Aust 2009; 191: 310-314.
12. Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831.
13. Whiteman DC, Sadeghi S, Pandeya N et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57: 173-180.
14. Vaughan TL, Davis S, Kristal A et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4: 85-92.
15. Brown LM, Silverman DT, Pottern LM et al. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control 1994; 5: 333-340.
16. Gammon MD, Schoenberg JB, Ahsan H et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89: 1277-1284.
17. Australian Institute of Health and Welfare (AIHW). Australian Cancer Incidence and Mortality Books (ACIM). Canberra, Australia: AIHW 2012.
18. Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Research Data, Nov 2010 Sub (1973-2008) -Linked To County Attributes-Total U.S., 1969-2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011 (updated 10/28/2011), based on the November 2010 submission (www.seer.cancer.gov).
19. Swedish Cancer Registry, The National Board of Health and Welfare. www. socialstyrelsen.se/statistics (27 January 2012, date last accessed).
20. Yu B, Barrett MJ, Kim H-J et al. Estimating joinpoints in continuous time scale for multiple change-point models. Comput Stat Data Anal 2007; 51: 2420-2427.
21. Kim HJ, Fay MP, Feuer EJ et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
22. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 1987; 6: 469-481.
23. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 1987; 6: 449-467.
24. Zheng TZ, Mayne ST, Holford TR et al. Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89. Cancer Causes Control 1992; 3: 481-492.
25. Olsen CM, Pandeya N, Green AC et al. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal Junction. Am J Epidemiol 2011; 174: 582-590.
26. Lagergren J, Ye WM, Bergstrom R et al. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. J Am Med Assoc 2000; 284: 961-962.
27. Cook MB, Kamangar F, Whiteman DC et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the International BEACON Consortium. J Natl Cancer Inst 2010; 102: 1344-1353.
28. Walls HL, Wolfe R, Haby MM et al. Trends in BMI of urban Australian adults, 1980-2000. Public Health Nutr 2010; 13: 631-638.
29. National Health Survey: Summary of Results, 2007-2008. Cat. no. 4364.0. Canberra, Australia: Australian Bureau of Statistics 2009.
30. Kuczmarski RJ, Flegal KM, Campbell SM et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. J Am Med Assoc 1994; 272: 205-211.
31. Flegal KM, Carroll MD, Kuczmarski RJ et al. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes 1998; 22: 39-47.
32. Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999-2008. J Am Med Assoc 2010; 303: 235-241.
33. Lissner L, Johansson SE, Qvist J et al. Social mapping of the obesity epidemic in Sweden. Int J Obes 2000; 24: 801-805.
34. Sundquist K, Qvist J, Johansson SE et al. Increasing trends of obesity in Sweden between 1996/97 and 2000/01. Int J Obes 2004; 28: 254-261.
35. Neovius M, Teixeira-Pinto A, Rasmussen F. Shift in the composition of obesity in young adult men in Sweden over a third of a century. Int J Obes 2008; 32: 832-836.
36. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. J Am Med Assoc 2006; 295: 1549-1555.
37. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 872-878.
38. Abrams JA, Sharaiha RZ, Gonsalves L et al. Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry Data, 1940-2007. Cancer Epidemiol Biomarkers Prev 2011; 20: 183-186.
39. Abnet CC, Freedman ND, Hollenbeck AR et al. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 2008; 44: 465-471.
40. Ness-Jensen E, Lindam A, Lagergren J et al. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut 2011; doi:10.1136/gutjnl-2011-300715.
41. Banatvala N, Mayo K, Megraud F et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219-221.
42. Whiteman DC, Parmar P, Fahey P et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010; 139: 73-83.
43. Thrift AP, Pandeya N, Smith KJ et al. Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer 2012; 130: 2407-2416.
44. Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol 2012; 175: 54-59.
45. Medicare Benefits Schedule (MBS) Item Statistics Reports. www. medicareaustralia.gov.au/statistics/mbs_item.shtml (20 March 2012, date last accessed).
46. Guda NM, Vakil N. Proton pump inhibitors and the time trends for esophageal dilation. Am J Gastroenterol 2004; 99: 797-800.
47. Hermansson M, Ekedahl A, Ranstam J et al. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002. BMC Gastroenterol 2009; 9: 25.
48. Nason KS, Wichienkuer PP, Awais O et al. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis. Arch Surg 2011; 146: 851-858.